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Aim. To identify novel ITSN1 and ITSN2 partners among RNA-binding proteins (RBPs) 
involved in the regulation of mRNA processing. Methods. The interactions were revealed 
using GST pull-down and immunoprecipitation assays whereas bioinformatics analysis was 
used to identify other RBPs that could interact with proteins ITSN1 and ITSN2. Results. It 
was shown that ITSN1 and ITSN2 SH3 domains interacted with nuclear RBPs SAM68, 
WBP11, and LARP6 in vitro. Next, it was found that ITSN1 and ITSN2 co-precipitated with 
SAM68 and LARP6 from 293 cells lysates. Finally, the bioinformatics analysis identified more 
than 500 nuclear RBPs that contain several SH3 domain-interacting proline motifs and could 
bind ITSN1/2. Conclusions. ITSN1 and ITSN2 SH3 domains bind nuclear RBPs SAM68, 
LARP6, and WBP11 in vitro, form complexes with SAM68 and LARP6 in 293 cells, and 
potentially could interact with other nuclear RBPs containing SH3 domain-interacting motifs.
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Introduction
Scaffold proteins represent a group of biomol-
ecules that are involved in the modulation of 
various cellular processes. These proteins are 
composed of multiple protein-interacting do-
mains and serve as platforms for the formation 
of functional protein complexes [1]. Intersectins 
(ITSN1 and ITSN2) are evolutionarily con-
served scaffold proteins encoded by two paral-
ogous genes. Short isoforms of ITSN1 
(ITSN1s) and ITSN2 (ITSN2s) possess identi-
cal domain structure and consist of two Eps15 
homology domains (EH) that bind Asp-Pro-
Phe (NPF) motifs, a coiled-coil region provid-
ing homo- and heterodimerization and five 
SH3 domains that interact with proline-rich 
motifs [2]. Long isoforms of ITSN1 (ITSN1l) 
and ITSN2 (ITSN2l) contain additional 
C-terminal DH-PH-C2 domains involved in 
the specific activation of GTPase Cdc42 [3]. 
ITSN1s, ITSN2s and ITSN2l are expressed 
ubiquitously whereas ITSN1l is expressed only 
in neurons [4].  ITSN1/2 are known to interact 
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with proteins involved in clathrin-mediated 
endocytosis and actin cytoskeleton remodeling, 
as well as with components of some cell sig-
naling cascades including MAPK-, PI3KC2β-, 
and JNK-mediated pathways [4].
ITSN1 and ITSN2 were found to be in-
volved in oncogenesis. First, ITSN1 overex-
pression induces the oncogenic transformation 
of rodent fibroblasts [5] and stimulates the 
invadopodia formation [6]. Second, overex-
pression of ITSN1 is associated with the de-
velopment of neuroblastoma [7, 8] and glio-
blastoma [9, 10, 11]. However, the ectopic 
expression of ITSN1 suppresses the prolifera-
tion, growth and migration of lung cancer 
cells [12]. Similarly, high levels of ITSN2 in 
breast cancer patients are associated with pro-
longed disease-free survival [13].
Previously, the analysis of HeLa nuclei 
phosphoproteome identified ITSN1 peptides 
in the nuclei of HeLa cells [14]. More re-
cently, ITSN1 has been found to undergo nu-
cleus-cytoplasmic shuttling via CRM1- and 
importin α-dependent pathways and has been 
shown to co-localize with lamin A/C [15]. The 
data supports our observations revealing nu-
clear localization of ITSN1 (unpublished data). 
However, the role of nuclear localization of 
ITSN1 is unknown.
Several high-throughput studies based on 
the results of two-hybrid screenings [16, 17] 
and phage display [18] identified ITSN1/2 
proteins as putative partners of nuclear RNA- 
and DNA-binding proteins whereas the role of 
the protein complexes in a cell is unknown. 
We suggested that ITSN1/2 SH3 domains play 
an essential role in the interaction between 
ITSN1/2 and RNA-binding-proteins (RBPs) 
as multiple RBPs possess proline-rich motifs 
that directly interact with SH3 domains where-
as ITSN1/2-RBPs complexes might be in-
volved in novel nucleus-cytoplasm crosstalk 
pathways.
Therefore, the current work aimed to confirm 
the interactions between ITSN1/2 proteins and 
RBPs identified in different high-throughput 
studies using GST pull-down and immunopre-
cipitation assays. Moreover, using a bioinfor-
matics approach, we analyzed RBPs present in 
human proteome to find additional proline-rich 
motifs as potential ITSN1/2-binding sites.
Materials and Methods
Expression constructs. The plasmids encoding 
human GST-fused SH3 domains-containing 
fragment of ITSN1 and ITSN2 were described 
previously [19, 20]. SAM68-GFP was a kind 
gift of Dr. D. J. Elliott [21], WBP11-GFP was 
received from Dr. M.Bollen [22], and LARP6-
GFP was obtained from Dr. L. M. Schwartz 
[23]. 
Antibodies. Rabbit polyclonal antibodies 
against ITSN1 and ITSN2 were described pre-
viously [19, 20]. Polyclonal anti-GFP antibod-
ies were a kind gift of Dr. V. V. Filonenko. 
Secondary HRP-labeled anti-rabbit antibodies 
were purchased from Promega.
Cell culture and transfection. 293 cells were 
maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10 % 
fetal bovine serum (Sigma), 50 mg/ml penicil-
lin and 100 mg/ml streptomycin. The cells 
were transiently transfected using JetPEI trans-
fection reagent (Polyplus Transfection) accord-
ing to recommended protocol and were pro-
cessed 24 h following transfection.
Pull-down assay. The recombinant GST-
fused proteins were produced in Escherichia 
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coli Top10 cells and purified using glutathione-
Sepharose 4B (GE Healthcare) according to 
the manufacturer‘s protocol. Lysates of tran-
siently transfected 293 cells were prepared in 
extraction buffer containing 20 mM Tris-HCl 
pH 7.4, 150 mM NaCl, 0.5 % Triton X-100, 1 
mM EDTA and 1 mM phenylmethylsulfonyl-
fluoride (PMSF) and centrifuged for 10 min at 
12.000 rpm at 4°C. For pull-down experi-
ments, 5–10 μg of GST or GST-fused proteins 
were bound to 30 μl of 50 % glutathione-
Sepharose 4B beads and incubated with the 
293 cell lysates for 1 h at 4°C. After extensive 
washing, the beads were boiled in Laemmli 
sample buffer.
Immunoprecipitation assay. The immuno-
precipitation was performed as described pre-
viously [20]. In brief, 293 cells were lysed in 
IP buffer (150 mM NaCl, 20 mM Tris, pH 7.5, 
10 % glycerol, 0.5 % NP40, protease inhibitors 
cocktail (Roche) and centrifuged for 15 min 
at 12,000 rpm. The supernatant (2 mg of pro-
teins) was incubated with 2 µg of anti-ITSN1 
or anti-ITSN2 antibodies and 20 µl of Protein 
G-conjugated agarose beads (Santa Cruz 
Biotechnology) for 4 h at 4°C. Then, beads 
were washed three times with IP buffer and 
boiled in Laemmli sample buffer.
Western blot. Protein samples in Laemmli 
buffer were resolved by SDS-PAGE and trans-
ferred to nitrocellulose membranes (Bio-Rad). 
The membranes were blocked with 5 % non-fat 
milk in TBS-T (1xTBS, 0.1 % Tween 20) for 
1 h, incubated with anti-GFP, anti-ITSN1 or 
anti-ITSN2 antibodies for 1 h and washed. 
Next, membranes were incubated with HRP-
conjugated secondary anti-rabbit antibodies 
for 1 h. Immunoreactive bands were detected 
using ECL reagents. Chemiluminescence was 
captured with Molecular Imager ChemiDoc™ 
XRS+ (Bio-Rad).
Bioinformatics analysis. A list of human 
RNA-binding proteins was composed using 
RBPs Databases ATtRACT [24] (last accessed 
December 21, 2018) and RBPDB [25] (last 
accessed December 21, 2018) and QuickGO 
annotation service [26] (last accessed January 
28, 2019) where proteins annotated with GO 
terms “RNA binding” (GO:0003723) and “ex-
perimental evidence used in manual assertion” 
(ECO:0000269) were obtained. A list of pro-
teins that localize in a cell nucleus was also 
obtained from QuickGO service using GO 
term “Nucleus” (GO:0005634). Amino acid 
sequences of the selected RBPs were acquired 
from the UniProt database (https://www.uni-
prot.org/, last accessed December 21, 2019). 
Proline-rich motifs (PxxP, RxxPxxP, PxxPxR) 
that potentially interact with SH3 domains 
were searched in the amino acid sequences of 
RBPs automatically using Python scripts.
Results and Discussion
The putative interaction between ITSN1/2 and 
several RNA-binding proteins was studied in 
vitro. For the purpose, a GST pull-down assay 
was performed to analyze the binding of 
ITSN1/2 SH3 domains to the putative part-
ners. The selected RNA-binding proteins in-
cluded SAM68 (Src-Associated substrate in 
Mitosis of 68 kDa), WBP11 (WW Domain 
Binding Protein 11), and LARP6 (La 
Ribonucleoprotein Domain Family Member 
6). All these proteins contain several PxxP 
motifs that can potentially interact with 
ITSN1/2 SH3 domains. As a result, recombi-
nant proteins representing SH3-containing 
fragments of ITSN1 (ITSN1SH3) and ITSN2 
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Fig. 1. The SH3 domains of ITSN1 (A, B, C) and ITSN2 (D, E, F) interact with RNA-binding proteins SAM68 (A, 
D), WBP11 (B, E) and LARP6 (C, F). Following GST pull-down assay and SDS-PAGE, GST-fused SH3 domains of 
ITSN1 and ITSN2 were visualized using Ponceau staining whereas GFP-fused RBPs were detected using α-GFP an-
tibodies. The relative amounts of RBP bound to GST or GST-ITSN1/2SH3 were calculated using ImageJ software. 
Histograms represent mean ± SD values obtained from three separate assays. WB – Western blotting, TCL – total cell 
lysate, a.u. – arbitrary units.
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D
B
E
C
F
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(ITSN2SH3) fused to GST were immobilized 
on the glutathione sepharose and incubated 
with the lysates of 293 cells overexpressing 
one of the target proteins. Recombinant GST 
alone was used as a negative control. 
Following gel electrophoresis, GST-fused 
ITSN1SH3 and ITSN2SH3 were detected with 
Ponceau staining whereas precipitated pro-
teins were detected by Western blot. The anal-
ysis demonstrated that ITSN1 SH3 domains 
precipitated all studied RNA-binding proteins 
(Fig. 1 A, B, C) whereas SAM68 showed the 
most significant binding. Similar data were 
obtained for ITSN2 SH3 domains that showed 
binding to all analyzed RNA-binding and 
strong interaction with SAM68 (Fig. 1 D, E, 
F). These data suggest that ITSN1 and ITSN2 
interacted with RBPs SAM68, WBP11 and 
LARP6 in vitro.
Immunoprecipitation assay was used to ob-
tain the formation of complexes between 
ITSN1/2 proteins and selected RBPs in 293 
cells. For this purpose, antibodies specific to 
ITSN1 or ITSN2 were immobilized on protein 
G-containing agarose beads and were incubated 
with the lysates of 293 cells overexpressing one 
of the target proteins. ITSN1/ITSN2-containing 
protein complexes were precipitated and ana-
lyzed using Western blot analysis. The data 
demonstrated that both ITSN1 and ITSN2 pre-
cipitated SAM68 and LARP6 suggesting that 
ITSN1 and ITSN2 form complexes with SAM68 
and LARP6 in cells (Fig. 2 A, C, D, F). However, 
ITSN1 and ITSN2 failed to precipitate WBP11 
Fig. 2. Endogenous ITSN1 (A, C) and ITSN2 (D, F) precipitate RBPs SAM68 (A, D) and LARP6 (C, F) but did not 
precipitate WBP11 (B, E) overexpressed in 293 cells. Following immunoprecipitation assay and SDS-PAGE, precipi-
tated proteins ITSN1s (short isoform) or ITSN2s and ITSN2l (short and long isoforms, respectively) were visualized 
using respective antibodies and ECL detection. Next, the same nitrocellulose membrane was re-incubated with α-GFP 
antibodies to identify co-precipitated RBPs. IP – immunoprecipitation, NRS – normal rabbit serum, WB – Western 
blot, TCL – total cell lysate.
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(Fig. 2 B, E) that might be caused by the absence 
of specific external (i.e., mitogenic stimulation) 
or internal (i.e. posttranslational modification) 
factors facilitating the interaction.
As multiple RNA-binding proteins contain 
proline-rich regions, we suggested that ITSN1 
and ITSN2 could interact with other RBPs. As 
a result, we used bioinformatics analysis to 
screen amino acid sequences of human RBPs 
for the presence of SH3 domain-interacting 
motifs. Using information from RBPs data-
bases and QuickGO service, we identified 
1383 RBPs whereas 823 RBPs localized in the 
nucleus. Next, the presence of proline motifs 
(PxxP and RxxPxxP/PxxPxR) that are spe-
cifically recognized by ITSN1/2 SH3 domains 
[27] was studied. The analysis demonstrated 
that most of RBPs contained at least one PxxP 
motif and almost 28 % of RBPs contained at 
least one RxxPxxP or PxxPxR motif. The re-
sults of the analysis are visualized in the form 
of Venn diagram (Figure 3A) demonstrating 
the number of unique and overlapping RBPs 
according to the studied properties. 
However, as one motif might be insufficient 
for the interaction, or it may be localized inside 
a protein fold, the number of PxxP and 
RxxPxxP/PxxPxR motifs in RBPs was ana-
lyzed. As we were interested in the identifica-
tion of putative ITSN1 partners localized in 
the nucleus, the number of proline motifs in 
nuclear RBPs is shown (Figure 3B). According 
to the frequency distribution, nuclear RBPs 
were characterized by various numbers of pro-
line motifs. Putative ITSN1/2 partners that 
were identified in the current study (SAM68, 
WBP11, and LARP6) significantly differed in 
the number of proline motifs. Similar fre-
Fig. 3. Multiple RNA binding proteins contain SH3 domain-interacting proline motifs. A – Venn diagram demonstrat-
ing a number of all RBPs, nuclear RBPs, and RBPs containing at least one indicated proline motif found in human 
proteome. B – A histogram showing the frequency of occurrence of certain number of proline motifs identified in 
nuclear RBPs. 
A B
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quency distribution was obtained for cytoplas-
mic RBPs (data not shown). As a result, it 
might be suggested that other nuclear and 
cytoplasmic RBPs containing functional pro-
line motifs could form complexes with ITSN1 
and ITSN2 similar to Sam68 and LARP6. 
However, the experimental evidences are re-
quired to confirm the putative interactions.
The present data revealed the interaction 
between ITSN1/2 proteins and RNA-binding 
proteins SAM68 and LARP6. Sam68 is in-
volved in the regulation of mRNA processing 
including its transcription and splicing [28]. In 
particular, SAM68 modulates the transcrip-
tional activity of acetyl-transferase CBP [29], 
regulates the expression of cyclins D1 and E 
[30], controls the activation of c-myc targeted 
genes [31], and is involved in the regulation of 
androgen receptor-mediated transcription [32]. 
As a regulator of alternative splicing, SAM68 
induces the production of prooncogenic iso-
forms of CD44, CCND1, ASF/SF2, and BIRC5 
[28]. Additionally, the interaction between 
SAM68 and some SH3 domain-containing pro-
teins (i.e., kinases and methyltransferases) af-
fects its RNA- and protein-binding properties 
[28]. Moreover, the SAM68 overexpression is 
observed in different cancer types (breast, glio-
blastoma, prostate) [28]. LARP6 was found to 
stimulate the expression of metalloprotease 
MMP-9. The overexpression of LARP6 is also 
observed in breast cancer tumors and cell lines 
[23, 29]. Additionally, LARP6 stimulates an-
giogenesis and tumor growth [23]. On the oth-
er hand, accumulation of ITSN1 in the nucleus 
leads to the alteration of the expression of im-
mediate response genes (MYC, EGR1, and FOS) 
whereas the ITSN1 knockdown causes the in-
creased production of proapoptotic isoform of 
ASF/SF2 (unpublished data). As ITSN1 lacks 
RNA- and DNA-binding motifs, it could be 
suggested that the effect of ITSN1 on the ob-
served nucleus-specific processes is mediated 
by RNA-binding proteins including SAM68 or 
LARP6 and could be associated with pro- or 
anti-oncogenic signalling. The identification of 
multiple proline motifs-containing RBPs sup-
ports the suggestion that ITSN1/2 proteins 
might interact with other proteins involved in 
RNA processing although the functional con-
sequence of possible interactions is still un-
known. As a result, it can be suggested that the 
interaction between ITSN proteins and nuclear 
RBPs could serve as a link between signaling 
processes in the cytoplasm and RNA processing 
in the nucleus. However, further analysis is 
needed to confirm the predictions and find out 
their functional role.
Conclusion
The SH3 domains of ITSN1 and ITSN2 inter-
acted with the nuclear RNA-binding proteins 
SAM68, WBP11 and LARP6 in vitro whereas, 
in 293 cells, ITSN1/2 scaffolds formed the 
protein complexes with SAM68 and LARP6. 
Moreover, human proteome contains a large 
number of other nuclear RBPs that have puta-
tive SH3 domain-interacting proline-rich re-
gions which could potentially interact with 
ITSN1 and ITSN2. Overall, it could be sug-
gested that ITSN-RBPs complexes could be 
involved in the regulation of mRNA processing 
although the molecular basis of the potential 
relationship requires further analysis.
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Скафолдні білки ITSN1 та ITSN2 взаємодіють 
із ядерними РНК-зв’язуючими білками
С. В. Паньківський, Н. В. Сенченко, П. Б. Бусько, 
А. В. Риндич
Мета. Виявити нових партнерів ITSN1 і ITSN2 з-поміж 
РНК-зв’язуючих білків (RBP), що беруть участь в 
регуляції процесингу мРНК. Методи. Взаємодії були 
проаналізовано з використанням GST pull-down assay 
та імунопреципітації, тоді як біоінформатичний аналіз 
було використано для ідентифікації інших RBP, які 
могли б взаємодіяти із білками ITSN1 та ITSN2. 
Результати. Було показано, що SH3 домени білків 
ITSN1 та ITSN2 взаємодіють з ядерними RBP SAM68, 
WBP11 і LARP6. Крім того, було виявлено, що ITSN1 
та ITSN2 копреципітувались із SAM68 і LARP6 із лі-
затів клітин лінії 293. Біоінформатичний аналіз пока-
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зав, що існує більше 500 ядерних RBP, які містять 
кілька пролінових мотивів, що можуть взаємодіяти із 
SH3 доменами білків ITSN1/2. Висновки. SH3 домени 
білків ITSN1 і ITSN2 взаємодіють із ядерними RBP 
SAM68, LARP6 і WBP11 in vitro, утворюють комплек-
си із SAM68 і LARP6 в клітинах лінії 293 і потенційно 
можуть взаємодіяти з іншими ядерними RBP, що міс-
тять мотиви, які зв’язуються із SH3 доменами.
К л юч ов і  с л ов а: ITSN1, ITSN2, РНК-зв’язуючі 
білки.
Скаффолдные белки ITSN1 и ITSN2 
взаимодействуют с ядерными РНК- 
связывающими белками
С. В. Паньковский, Н. В. Сенченко, П. Б. Бусько, 
А. В. Рындич
Цель. Найти новых партнеров ITSN1 и ITSN2 среди 
РНК-связывающих белков (RBP), участвующих в ре-
гуляции процессинга мРНК. Методы. Взаимодействия 
были проанализированы с использованием GST pull-
down assay и иммунопреципитации, тогда как биоин-
форматический анализ был проведен для идентифи-
кации других RBP, которые могли бы взаимодейство-
вать с белками ITSN1 и ITSN2. Результаты. Было 
показано, что SH3 домены белков ITSN1 и ITSN2 
взаимодействуют с ядерными RBP SAM68, WBP11 и 
LARP6. Кроме того, было обнаружено, что ITSN1 и 
ITSN2 копреципитировались с SAM68 и LARP6 из 
лизатов клеток линии 293. Биоинформатический ана-
лиз показал, что существует более 500 ядерных RBP, 
содержащие несколько пролиновых мотивов, которые 
могут взаимодействовать с SH3 доменами белков 
ITSN1/2 в ядре клетки. Выводы. SH3 домены белков 
ITSN1 и ITSN2 взаимодействуют с ядерными RBP 
SAM68, LARP6 и WBP11 in vitro, образуют комплексы 
с SAM68 и LARP6 в клетках линии 293 и потенциаль-
но могут взаимодействовать с другими ядерными RBP, 
содержащими мотивы, которые связываются с SH3 
доменами.
К л юч е в ы е  с л ов а: ITSN1, ITSN2, РНК-свя зы ваю-
мщие белки
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